Franklin Resources
SGNT

Franklin Resources’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Franklin Resources’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,641,004
Closed -$24.6M – 1551
2016
Q2 		$24.6M Sell
1,641,004
-131,440
-7% -$1.69M 0.01% 746
2016
Q1 		$21.6M Sell
1,772,444
-1,217,124
-41% -$17.1M 0.01% 793
2015
Q4 		$47.6M Sell
2,989,568
-902,389
-23% -$14.2M 0.02% 564
2015
Q3 		$59.7M Sell
3,891,957
-281,723
-7% -$6.09M 0.03% 494
2015
Q2 		$101M Buy
4,173,680
+184,669
+5% +$4.42M 0.05% 388
2015
Q1 		$92.7M Sell
3,989,011
-423,821
-10% -$11.2M 0.04% 413
2014
Q4 		$111M Sell
4,412,832
-1,275,321
-22% -$37.4M 0.05% 353
2014
Q3 		$177M Sell
5,688,153
-632,140
-10% -$17.1M 0.08% 247
2014
Q2 		$163M Buy
6,320,293
+619,264
+11% +$13.8M 0.07% 275
2014
Q1 		$133M Buy
5,701,029
+1,181,011
+26% +$25.8M 0.06% 308
2013
Q4 		$115M Buy
4,520,018
+569,681
+14% +$12.9M 0.06% 334
2013
Q3 		$80.6M Buy
+3,950,337
New +$87.9M 0.04% 418

Franklin Resources's SGNT Position: Q3 2016 in Review

Franklin Resources sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,641,004 shares — an estimated $24.6M sold.

Franklin Resources first reported a position in SGNT in Q3 2013 and held it in 12 quarters. The position peaked at $177M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Franklin Resources reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Franklin Resources sold 1,641,004 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $24.6M.
  • Franklin Resources first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 12 quarters.
  • Franklin Resources's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $177M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Franklin Resources's 13F filing for Q3 2016, filed 14 Nov 2016.